Business Strategy
Phylogica is a specialist drug discovery Company offering peptide discovery services to the pharmaceutical industry in exchange for upfront licence fees, milestone payments and a share in revenue arising from any drugs discovered as a result of the Company’s research.
The Company also aims to add enterprise value through internal discovery programmes and enhancements to its intellectual property portfolio, which increases potential for further licensing deals and may also make the Company an attractive merger or acquisition candidate.
For further information please download PDF below:
